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Simple Summary: There is an increasing demand for information on the nutraceutical properties of
food. Due to its bioactive components and high digestibility, goat milk is an excellent functional food.
Dietary fat supplementation can further enrich the value of goat milk by modifying its acidic profile.
Nevertheless, animal health can also benefit from lipids supplied with rations. In this review, the
relationships between dietary fats and goat health status are summarized. Particular attention is paid
to describing the effects of specific fatty acids on lipid metabolism and immune functionality.
Abstract: Fat supplementation has long been used in dairy ruminant nutrition to increase the fat
content of milk and supply energy during particularly challenging production phases. Throughout
the years, advances have been made in the knowledge of metabolic pathways and technological
treatments of dietary fatty acids (FAs), resulting in safer and more widely available lipid supplements.
There is an awareness of the positive nutraceutical effects of the addition of eicosapentaenoic acid
(EPA) and docosahexaenoic acid (DHA) to fat supplementation, which provides consumers with
healthier animal products through manipulation of their characteristics. If it is true that benefits
to human health can be derived from the consumption of animal products rich in bioactive fatty
acids (FAs), then it is reasonable to think that the same effect can occur in the animals to which the
supplements are administered. Therefore, recent advances in fat supplementation of dairy goats with
reference to the effect on health status have been summarized. In vivo trials and in vitro analysis on
cultured cells, as well as histological and transcriptomic analyses of hepatic and adipose tissue, have
been reviewed in order to assess documented relationships between specific FAs, lipid metabolism,
and immunity.
Keywords: transition dairy goat; polyunsaturated fatty acids; lipid metabolism; immune response
1. Introduction
In recent years, the identification of various biologically active components in ruminant milk
and dairy products, coupled with the growing attention of general consumers with respect to the
nutraceutical and health properties of food, has generated interest on their potential beneficial effects on
human health [1]. Goat milk has a high nutritional value and a large number of bioactive components [2].
Goat milk is also more easily digestible than bovine milk, mostly due to the higher β-casein fraction,
smaller diameter of fat globules, and the absence of agglutinins [3,4]. All these features make goat
milk a particularly appealing ‘functional food’.
Dietary manipulation of milk fatty acid (FA) composition represents an interesting approach to
further improve the biological and nutraceutical properties of dairy goats, with beneficial effects on
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both human and animal health. Generally, feedstuffs in the ruminant diet have a low content in lipids,
most of which are unsaturated in nature (unsaturated fatty acids, UFAs). In particular, forages are rich
in α-linolenic (C18:3n-3) and linoleic (C18:2n-2) acids [5], precursors of the n-3 and n-6 polyunsaturated
fatty acid (PUFA) lines, respectively. Conversely, cereals and oilseeds—mainly used to increase the
ration energy and lipid content—are richer in linoleic acid and oleic acid (C18:1n-9), a monounsaturated
fatty acid (MUFA) widely represented in dairy milk fat [6]. In contrast to what could be expected,
the FA profile of milk fat shows large differences from the dietary one. In fact, at least 60%–70% of dairy
milk fat is composed of saturated fatty acids (SFAs), with a remaining 20%–35% MUFAs and only up to
a 5% content in PUFAs [7]. These differences can be largely attributed to the rumen biohydrogenation
process. During the biohydrogenation process, a large fraction of dietary UFAs—ranging from 60%
to 90% [8,9]—undergo hydrolysis and several consecutive isomerization reactions that lead to their
saturation. By consequence, the main FAs that reach the duodenum are stearic acid (C18:0) and various
intermediates of reaction, mostly trans-isomers of oleic and linoleic acids [10,11]. PUFAs found in milk
fat derive from the small amount of rumen-escaped PUFAs and—in a minor part—by the enzymatic
activity of mammary ∆9 desaturase [12].
Nevertheless, it is undoubted how nutritional factors (forage type, forage/concentrate ratio, fat
sources) and feed processing can still easily affect the FA profile of milk. It has been proved that dairy
animals fed fresh forages and grazing grass produce milk higher in PUFAs compared to fodder-fed
animals [13,14], and that the type of pasture can affect FA profile [15]. Variations of milk FA content were
also reported as a consequence of different forage to concentrate ratios [16,17] as well as management
and farming systems [18,19]. Likewise, lipid supplements have proved to be effective in modulating
the acidic composition of milk [20–23]. In recent years several efforts have been made to increase the
n-3 PUFA content of milk in both cows and goats. While n-3 PUFAs have the potential to improve
long-term human health [24], unfortunately mammals are unable to synthetize them, a reason for
which they necessarily have to be integrated through the diet [25]. Long chain derivates of C18:3
n-3, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are the two main essential n-3
PUFAs. Due to their poor content in traditional ruminant diets, EPA and DHA are very scarcely
represented in dairy milk fat (<0.1% of total FAs) [26]. A possibility to enrich dairy ruminant milk with
EPA and DHA is to provide feedstuffs high in them (fish oil, marine algae) or high in their precursor
C18:3 n-3 (linseed). Common to dietary long-chain PUFAs, regardless of their source, is their low
milk transfer rate [21], ascribed mainly to their rumen biohydrogenation and to their poor intestinal
digestibility [27,28]. The effectiveness of dietary modulation of the milk FA profile can be increased
through technological treatments aimed at protecting dietary lipids from ruminal biohydrogenation,
such as emulsification [29], encapsulation [30], or supplementation with calcium salts [31]. Some
authors hypothesize that goats and ewes, due to their higher rumen transit compared to cows, would
be subjected to a lower biohydrogenation rate [32,33]. Data comparing FA transfer efficiency of goats
and cows are inconsistent among different studies [6,34,35].
The effects of dietary lipid supplementation on animal production [21,36,37] and reproductive
performance [38–40] are widely documented. On the other hand, there are fewer references to the
effects of dietary lipids on the health status of dairy ruminants. This review will attempt to summarize
current knowledge about lipid supplementation in dairy goats, with reference to the effect on lipidic
metabolism and immune response.
2. Fat Supplementation and Lipid Metabolism
In the scientific literature it is possible to find a conspicuous number of references about the effects
of dietary lipids on ruminant metabolism. Most of the studies, however, are more focused on lipid
metabolism of the mammary gland, in order to identify the consequences in terms of production.
Long-chain PUFAs (EPA and DHA) at the ruminal level are able to disrupt the biohydrogenation
process, inhibiting ruminal conversion to stearic acid [41,42]. The effect of EPA and DHA on rumen
lipid metabolism is of considerable interest, as it can be exploited to modify the acidic profile of the
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milk. In an experimental trial conducted by Póti et al. [22], the administration of marine algae for
a period of 16 days markedly modified the acidic profile of goat milk, with an increased concentration
of PUFAs, MUFAs, and n-3 FAs, while reducing levels of SFAs. The shift in the rumen microbial
population induced by PUFA supplementation, and the consequent increase in trans-intermediates of
the linolenic acid biohydrogenation, also affects milk conjugated linoleic acid (CLA) content [43–45].
Beneficial effects on human health are attributed to CLAs, such as protection from cancer and
obesity, as well as anti-atherogenic and anti-diabetic properties [46]. Despite all these positive effects
on the acidic composition of milk, the activity of PUFAs at the ruminal level is also considered
to be the main cause of the reduction in the fat content of milk, a phenomenon often detected
following fat supplementation [20,21]. Several trans-CLA reaction intermediates resulting from the
incomplete ruminal biohydrogenation of FA are supposed to inhibit the mammary synthesis of FAs.
These trans-CLA intermediates exhibit anti-lipogenic effects of variable magnitudes. In particular,
trans10-cis12-CLA has been demonstrated to be partly responsible for milk fat depression (MFD) in
dairy cows [47,48]. In a study by Zhang et al. [49], trans10-cis12-CLA downregulated the expression of
various genes involved in de novo FA synthesis (FASN, SCD1, ACACA) in caprine mammary gland
epithelium in vitro. The reason behind such an effect are still to be clarified. In a recent study by
Vargas-Bello-Perez et al. [50] on goat mammary cells, saturated long-chain fatty acids, in particular
stearic acid, were able to modulate milk fat synthesis partly via peroxisome proliferator-activated
receptor (PPAR)γ, while PPARγ had an indirect role on PUFA regulation of milk fat-related genes:
in particular it had a permitting effect for trans10-cis12-CLA and a blocking effect for DHA. Of note,
other studies seem to indicate that trans10-cis12-CLA plays a less important role in dairy goats
supplemented with fish oil than in dairy cows [35]. Whether this finding depends on differences in
the responsiveness of the two species or species-specific lipogenic genes pathways is still unclear.
Bernard et al. [51] found that goats were susceptible to MFD when supplemented fish oil but not
sunflower oil, unlike cows in which milk fat content dropped in response to both treatments. Since
various reports pointed out the relatively low sensitivity of the caprine species to the anti-lipogenic
effects of ruminal biohydrogenation intermediates [35,52], fish oil-induced MFD experienced by goats
in the latter study could be attributed to mechanisms other than direct trans-intermediate activity.
An hypothesis in this regard takes into account the ∆9-desaturase-mediated conversion of milk C18:0
(positively related to milk fat content in goats) to cis-9 C18:1, in order to reduce the milk fat fluidity
to adequate levels for milk secretion [53–55]. This theory seems to find confirmation in the study
conducted by Toral et al. [35], who recorded a significant decrease in milk C18:0 and cis9 C18:1 content
and an increase in cis-9 C18:1/C18:0 ratio in both cows and goats when supplemented with fish oil.
In spite of this, dietary C18:0 supplementation proved ineffective in mitigating fish oil-induced MFD in
dairy ewes [56]. Moreover, Bernard et al. [51] underlined that lipogenic genetic pathway in mammary
gland differed between the bovine and caprine species. In line with the latter finding are those of
Suárez-Vega et al. [57], who evidenced how MFD induced by CLA supplementation was characterized
by a wider downregulation of adipogenic genes in dairy ewe mammary glands than fish oil-induced
ones; moreover, CLA-induced MFD but not fish oil-induced MFD affected genes involved not only
in FA synthesis, but also in immune response, as evidenced by the milk somatic cell transcriptome
analysis. In this regard, Zhang et al. [49] found that trans10-cis12-CLA increased the concentration
of lipid droplets in caprine mammary gland cells. As discussed later on, an increase in lipid droplet
content in the goat leukocyte cytoplasm is associated with the activation of immune and inflammatory
mechanisms [58].
A more limited number of studies are aimed at evaluating the effects of fat supplementation on
lipid metabolism in other organs and tissues. Fat supplementation seems indeed to influence lipid
metabolism not only in the mammary gland but also in other organs of primary importance for animal
health, such as liver and adipose tissue.
In an experimental study conducted on 18 dairy goats, dietary supplementation with saturated
FA (hydrogenated palm oil) during the transition period proved effective in altering hepatic gene
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expression [43]. In particular, palm oil treatment caused an increase in peroxisome proliferator-activated
receptor α (PPARα) mRNA levels compared to a fish oil and basal diet. PPARα is a ligand-regulated
nuclear receptor that, upon activation by binding with specific ligands, increases the transcription of
genes involved in various lipid metabolism processes such as peroxisomal FA uptake and oxidation,
FA trafficking, and lipolysis [59]. Since it has been proved that PPARα can modulate its own gene
expression [60], it could be inferred that SFA supplementation can trigger PPAR biological activity.
In vitro studies on bovine kidney cells were also effective in proving stearate and palmitate are strong
activators of PPARα target genes [61]. The greater responsiveness of ruminant PPARα to SFAs is
in contrast to data obtained from non-ruminant studies [62] and seems to be related to differences
in spatial structure and electrostatic charge of their ligand binding domains [63]; this could reflect
a species-specific teleological adaptative mechanism in response to the composition of non-esterified
fatty acids (NEFAs: the major natural ligands and activators of PPARα), which in ruminant species
are mainly composed of SFAs [63]. This speculation seems to be in agreement with the results
obtained by Agazzi et al. [43], who recorded an increase in the mRNA levels of various PPARα target
genes involved in FA synthesis (ACACA) and intramithochondrial transportation (ACADVL, CPT
1A) in dairy goats supplemented with palm oil. Nonetheless, other studies pointed out how UFA
supplementation—compared to untreated basal diet—is still able to induce heighten PPARα gene
expression in goat liver [64]. In this regard, attention should also be paid to the dietary n-6 to n-3
ratio, since higher proportions of n-6 were found to downregulate PPARα and PPARγ gene expression
in goat muscle tissue [65]. In any case, mixed results were obtained by evaluating the expression
response of PPARα in to n-3 PUFA supplement in other goat tissues, being able to upregulate it in
muscle tissue [58] but proving to be ineffective in adipose tissue [66,67].
In a recent study conducted by Invernizzi et al. [68], liver and adipose tissue histological samples
from goats fed different FA sources were collected and evaluated. The trial comprised 23 goats in their
transition period—from −21 to 21 days in milk (DIM)—divided into three groups fed a basal diet,
a diet supplemented with strongly saturated FA (stearate), or a diet supplemented with unsaturated
FA (fish oil). Adipose tissue histology revealed that the reduction of adipocyte diameter (index of
lipomobilization) was confined to a more limited time frame in the fish oil-fed group (from −7 to 7 DIM)
compared to the other two groups (from −7 to 21 DIM) (Table 1). On the other hand, hepatocytes
of goats fed fish oil on day 21 had higher levels of vacuolated cells (a marker of mild to severe cell
suffering derived from lipomobilization) compared to the control and stearate group. Absence of
necrosis foci and pyknotic nuclei implies a higher degree of chronic adaptation to lipomobilization
compared to bovine species. The adaptation mechanism seemed to reach its highest in the fish oil
group, as supported by the more gradual increase in suffering hepatocytes. In addition to histology,
biochemical analysis was also performed and evidenced higher glycemic levels in both stearate- and
fish oil-fed groups than on control group, validating the effectiveness of the widespread practice of
supplementing fats during the peripartum to support the energy balance [69,70].
Table 1. Mean adipocyte area (µm2) of subcutaneous adipose tissue of dairy goats fed with a basal diet
(C), a diet supplemented with fish oil (FO), or stearic acid (ST) [68].
Time Treatment 1 p-Value 2
C SD FO SD ST SD Trt Time Trt × Time
−7 3200.00 d 1002 2877.69 d 876 3088.80 d 1010 0.60 <0.01 <0.01
7 1970.44 e 523 1801.80 e 548 2156.33 e 718
21 1157.74 b,f 216 1851.85 a,e 638 1066.66 b,f 269
a,b Values within each row with different superscripts are significantly different (p < 0.05). d–f Values within each
column with different superscripts are significantly different (p< 0.05). 1 SD, standard deviation 2 Trt, treatment effect.
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In subsequent studies, the same tissue samples were subjected to molecular analysis to investigate
the expression of genes involved in lipid metabolism [71,72]. In hepatic parenchyma, stearate-fed
animals exhibited a marked upregulation of the stearoyl-CoA desaturase (SCD) gene in the post-partum,
a trend opposite to that showed by the other two groups. SCD encodes for stearoyl-CoA desaturase,
a ∆9 desaturase analogous to that found in the mammary gland, thanks to which a small part of FAs
exposed to ruminal biohydrogenation are dehydrogenated. Moreover, two genes encoding for enzymes
involved in peroxisomal FA β-oxidation—ACOX1 and ACAA1—were upregulated pre-partum in both
stearate- and fish oil-fed groups, with the effect lasting longer in the fish oil group [72]. In adipose
tissue, the mRNA levels of the LPIN1 gene were heightened in both the experimental groups during the
post-partum, in accordance with the findings of other studies [73]. This effect was more pronounced
in the group supplemented with PUFAs. LPIN1 is a gene encoding for lipin-1, a protein found in
various anatomic district and with different functions closely related to lipid metabolism. Lipin-1 can
modulate lipomobilization through its activity: in response to high intracellular lipid content, lipin-1
acts as a phosphatidate phosphatase (PAP) enzyme, converting phosphatidic acid into diacylglycerol
and providing substrate for the synthesis of all classes of lipids while reducing free FA levels [74].
In addition to its PAP activity, lipin-1 also act as a co-binder of PPARα [75], promoting hepatic FA
β-oxidation, and exhibits pro-inflammatory activity [76]. By this view, the overexpression of LPIN1 in
adipose tissue of goats fed fish oil during the two weeks around parturition is consistent with what
was found during hepatic histological analysis by Invernizzi et al. [68], who reported a more restrained
level of lipid infiltration in these animals. Finally, FASN expression was downregulated in both dietary
treatments from –7 days before kidding to 7 days in milk. FASN is the gene encoding for fatty acid
synthase, and its reduction could be suggestive of decreased lipogenesis.
There is convincing evidence in caprine species also that maternal dietary fat supplementation
during gestation and lactation can influence the metabolism of the offspring in different ways, such
as altering their ruminal microbiome and adipose tissue proteome [77,78]. Some findings seem also
to imply that the modifications induced by FAs on lipid metabolism could have a certain degree of
heritability thanks to epigenetic mechanisms [79,80].
3. Fat Supplementation and Immune Response
The ability of specific FAs to modulate immune function and associated inflammatory processes
has long been known and reported in scientific literature [81,82]. In general, it is currently accepted that
dietary SFAs are related to increased risk of cardiovascular and coronary heart disease (CVD/CHD).
The etiopathogenetic mechanism behind the association between SFAs and CVD/CHD is likely to be
found in their tendency to raise blood low-density lipoprotein cholesterol levels [83]. Despite this,
dairy SFAs seem to have a smaller to neutral association with CVD/CHD risk compared to other dietary
sources [84,85], and there is evidence that at least some of them—including several CLAs—do not lead
to increased serum cholesterol values [86,87].
On the other hand, PUFA consumption—and in particular n-3 PUFAs—is considered beneficial
to human health [88]. Observational studies support this thesis, underlining the beneficial effects
associated with a lower SFA and a proportionally higher PUFA dietary regime [89,90].
n-3 PUFAs exert an anti-inflammatory action through different molecular mechanisms. Until
a few years ago it was widely believed that, thanks to their double bonds, PUFAs were able to fluidify
and stabilize cell membranes, avoiding activation of the arachidonic acid cascade and improving
cellular functionality [91]. To date, this hypothesis is considered controversial due to contradictory
results [92]. On the other hand, n-3 PUFA integration into the phospholipidic double layer is able
to modify the composition of lipid raft, affecting the activity of the protein receptors associated [93].
Among these proteins potentially modulated by n-3 PUFAs, some are involved in the activation of
both innate and acquired immune response, such as Major Histocompatibility Complex (MHC) [94]
and Toll-Like-Receptor 4 [95]. The effect of n-3 PUFAs on TLR-4, in particular, would also affect
inflammation on a secondary level, given the role played by TLR-4 in the activation of inflammatory
Animals 2019, 9, 917 6 of 14
gene pathways; in this way, n-3 PUFAs are able to indirectly silence genes involved in the activation
of the inflammatory cascade [96]. In addition, n-3 PUFAs also directly mitigate pro-inflammatory
signaling of some transcription factors, including nuclear factor kappa-light-chain-enhancer of activated
B cells (NFκB) [97,98]. In recent years, growing interest has surrounded a series of bioactive oxygenated
metabolites of PUFAs, namely oxylipins. The most well-known class of oxylipins is of pro-inflammatory
eicosanoids derived from arachidonic acid. Oxylipins act as signaling molecules, with a pro-or
anti-inflammatory action based on the PUFA line from which they originate. Simplifying, oxylipins
derived from n-6 PUFAs (arachidonic acid, linoleic acid) exhibit pro-inflammatory capacity, while
n-3-derived oxyplins are mainly anti-inflammatory [99]. Anti-inflammatory n-3-derived oxylipins
(resolvins, protectins, marensins) are called specialized pro-resolving mediators (SPM) by means of
their ability to resolve acute inflammatory states, protecting the body from various inflammatory
and metabolic insults and contributing to tissue regeneration [100]. Despite the PUFA precursor
line being a factor of primary importance in defining the pro-or anti-inflammatory oxylipin activity,
recent acquisitions on the topic have clarified how the biological activity of oxylipins depends
on a more than previously thought complex biosynthesis network modulated by multiple factors,
comprising the amount of PUFA precursors available and the tissue-specific enzymatic activity [101].
Moreover, emerging evidence shows how some of the anti-inflammatory effects of PUFAs could
be mediated by epigenetic mechanism [102], opening up fascinating scenarios about their putative
inter-generational effects.
The anti-inflammatory and immunomodulatory activity of n-3 is exploited in the field of animal
science to obtain products of animal origin characterized by specific nutraceutical properties, able to
provide a substantial contribution to protecting human health from pathological states. Nevertheless,
supplementing n-3 in the diet has also proved to be able to directly and positively influence the health
status of animals in their production phase.
Studies have been conducted in the past to assess the immunomodulatory effect of dietary n-3
PUFAs in goat, both in vivo and in vitro.
Goats fed a fish oil-supplemented diet during the transition period manifested a greater than
control group skin reaction to a phytohaemagglutinin (PHA)-challenge skin test after kidding [103,104],
demonstrating a higher level of cell-mediated immunity. Consistently, higher levels of circulating
lymphocytes were found in supplemented animals, indicating that fish oil was effective in contrasting
the drop of lymphocytes concentration and functionality occurring in the peripartum [105,106].
Supplementing n-3 PUFA to dairy goats altered the CD4+/CD8+ lymphocyte ratio during peripartum,
favoring the CD4+ subset (T-helper lymphocytes) [107]. By contrast, the administration of corn oil
rich in n-6 PUFAs reduced the surface expression of CD49d (α-4 integrin)—a subunit of lymphocytes
homing receptors that modulate tissue-specific cell trafficking—in lymphocytes of male castrated
goats [108].
In vitro studies evaluated leukocyte functionality in fat-supplemented goats. Pisani et al. [109]
found that neutrophils isolated from dairy goats produced less reactive oxygen species (ROS) (oxidative
burst) when exposed to various doses (25, 100, 200 µM) of DHA, but not of EPA. Results also pointed
out how even low doses (25 µM) were strongly effective in stimulating neutrophil phagocytic activity.
This data implies a positive effect of n-3 PUFAs on neutrophilic activity, favoring phagocytosis while
reducing extracellular release of ROS, that in situations of chronic and dysregulated inflammation can
be potentially harmful for the host tissues. Similar results were also found by Lecchi et al. [110] in goat
monocyte-isolated cells (Figure 1). A dose/effect dependence was identified, since the highest levels of
phagocytic activity were stimulated by low-to-mid doses of EPA (25–100 µM; >47%) and only mid doses
of DHA (100 µM; 25%). Higher doses of both EPA and DHA are not only shown to be ineffective on
cultured monocyte cells, but also detrimental, as evidenced by the increase in caspase-7 and caspase-3
pro-apoptotic activity [58]. Through the same study, treatment of caprine monocytes with EPA and
DHA caused a dose-dependent increase in intracytoplasmic lipid droplets. High-dose treatment
(>200 µM) with EPA also significantly upregulated mRNA of PLIN3, a gene encoding for a protein
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of the perilipin family (perilipin-3) which acts as a lipid droplet-associated protein contributing to
lipid droplets formation [111]. Recent developments in research have expanded knowledge about
lipid droplets, which are now recognized as structures actively involved in inflammatory and immune
processes [112].
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overexpression after kiddi g followed by a gradu l declin at 21 days after parturition. This effect
can be interpreted as a further confirmation of the differ nces in the bovine and cap ine metabolic
processes, th latter of which would seem to be characterized by a shorter duration and lower intensity
of the modifications of the metabolic and immune functionality typical of the peripart m. In the study,
quantitative PCR was also applied o evaluate the expressio o selected target micr RNA(miRNA).
As for mRNA, none of the sel cted miRNAs howed diet-dependen variations in expression lev ls, but
one miRNA associated with immune cell infiltration (miR-155) wa overexpresse in the two weeks
around kidding. D spite none of miRNAs directly ssociated with inflammation being overexpressed,
adipos tissue immune cell infiltration is strongly associated with lipolysis and adipose inflammation
phenomena c mmo ly displayed throughout the transition period [114]. Si ce to ur knowledg this
is the fir t report of miRNA nalysis performed on transiti dairy goats’ adipose tissue, whether
these findings are attributable to a real lack of effect or to th choice of target miRNA still needs to
be clarified.
4. Conclusions
Fat supplementation of the dairy goat diet is not considered a mere strategy to increase the
energetic level of the rations. Continuous advances in the knowledge of ruminant lipid metabolism,
coupled with the awareness of the multiple actions that specific FAs have on it, have led to their
application in order to modulate the specific characteristics of animal production, such as increasing
healthy UFA and CLA content. When opting to integrate fats into the diet in order to enrich the acidic
profile of the milk, particular attention should be paid to the choice of lipid sources. However, PUFA
supplementation has also shown its inhibitory effects on ruminal metabolism, with the consequent risk
of a drop in milk fat content (MFD). Even if in goats this effect is less pronounced than in cows and
sheep, to increase PUFA’s transfer efficiency in milk, a good strategy could be to use rumen-protected
or rumen inert fat supplements. To date, it is well known how adipose tissue does not only represent
a simple reserve of body fat, but it is also an endocrinally and paracrinally active tissue capable
of producing and secreting numerous lipid mediators. Similarly, dietary FAs exhibit modulatory
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capacities with respect to metabolic, inflammatory, and immune processes, through direct action on
receptors and transcription factors as well as through their bioactive oxygenated metabolites. Dietary
FAs exert a modulating action on the expression of several genes involved in lipid metabolism. These
effects are ubiquitous, occurring in various body tissues. As already mentioned, at the mammary
gland level the major implications of dietary FAs action are of a productive nature, with the potential
to modify the concentration and the acidic profile of milk fat. At the hepatic level the supplementation
of fat with the diet is correlated to variations in the expression of a pool of genes involved in lipid
metabolism. These effects seem to be more pronounced in the postpartum period, probably due to the
challenge represented by the metabolic changes that affect the first days in milk. Attention should be
paid also in this case to the class of FAs supplied, since SFAs and n-3 and n-6 PUFAs showed different
affinity and effects on target genes. In general, SFAs and n-3 PUFAs are both PPARα ligands, with SFAs
proven to be more effective ligands while n-6 PUFAs act as PPARα inhibitor. In addition, n-3 PUFA
supplementation was associated with higher expression of various genes involved in β-oxidation
and lipid mobilization in both hepatic and adipose tissue. Results from histological analysis of
liver tissue consistently showed lower and more gradual fatty infiltration in fat-supplemented goats,
particularly in those which received n-3 PUFAs. Regarding the immune modulatory activity of dietary
fats, signs of improved immune functionality in n-3 PUFA-supplemented goats were clear. It can
be assumed a beneficial effect of long-chain PUFAs on the host defense from non-specific immune
stimuli, an aspect that—coupled with the energy supply provided by lipids—can be particularly
useful during metabolic and immune stress conditions such as those that characterize the peripartum
period. Further studies should be carried out to investigate the relationship between dietary fats
and lipid droplets, intracellular organelles that are provoking a growing interest in relation to their
newfound active role in immune and inflammatory processes. Molecular analysis studies seem to be
more elusive, proving to be ineffective in identifying any correlations between dietary supplement
and inflammation- and immunity-related genes. Nonetheless, comparison with the most numerous
analogous studies on dairy cow allowed the identification of discrepancies between the two species
in the time trend and intensity of inflammation, lipomobilization, and immune modifications that
accompany parturition. In general, investigations on genetic pathway modifications can still prove
extremely useful to increase our knowledge on the complex ensemble of homeorhetic mechanism put
into action by ruminants in response to the metabolic and immune challenge they go through during
the peripartum. In this regard, particular mention should be given to the studies aimed at evaluating
goat miRNAs. Given the recent advances in understanding the epigenetic mechanisms underlying the
gene silencing functions of miRNAs, these studies can pave the way for new insights on the nutritional
modulation of transcriptomics (i.e., nutrigenomics).
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